ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc (RANI)

1.40
0.10
(7.69%)
Closed 22 December 8:00AM
1.4199
0.0199
(1.42%)
After Hours: 10:36AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.4199
Bid
1.39
Offer
1.42
Volume
453,989
1.30 Day's Range 1.415
1.30 52 Week Range 8.75
Market Cap
Previous Close
1.30
Open
1.33
Last Trade
1
@
1.42
Last Trade Time
Financial Volume
US$ 620,480
VWAP
1.3667
Average Volume (3m)
1,973,800
Shares Outstanding
57,288,682
Dividend Yield
-
PE Ratio
-2.38
Earnings Per Share (EPS)
-0.59
Revenue
-
Net Profit
-33.97M

About Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was US$1.30. Over the last year, Rani Therapeutics shares have traded in a share price range of US$ 1.30 to US$ 8.75.

Rani Therapeutics currently has 57,288,682 shares in issue. The market capitalisation of Rani Therapeutics is US$74.48 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -2.38.

RANI Latest News

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting...

Rani Therapeutics to Participate in Upcoming Investor Conferences

SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (β€œRani Therapeutics” or β€œRani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.3415-19.38798682871.76141.76141.37937951.46537615CS
4-0.6601-31.73557692312.082.161.35531641.76520026CS
12-0.7001-33.02358490572.123.751.319738002.68020252CS
26-2.4801-63.59230769233.94.371.39397732.69118906CS
52-1.7001-54.49038461543.128.751.35332632.94137895CS
156-16.3601-92.014060742417.7827.131.32145823.73255529CS
260-9.8401-87.389875666111.2636.271.32137075.54030954CS

RANI - Frequently Asked Questions (FAQ)

What is the current Rani Therapeutics share price?
The current share price of Rani Therapeutics is US$ 1.4199
How many Rani Therapeutics shares are in issue?
Rani Therapeutics has 57,288,682 shares in issue
What is the market cap of Rani Therapeutics?
The market capitalisation of Rani Therapeutics is USD 74.48M
What is the 1 year trading range for Rani Therapeutics share price?
Rani Therapeutics has traded in the range of US$ 1.30 to US$ 8.75 during the past year
What is the PE ratio of Rani Therapeutics?
The price to earnings ratio of Rani Therapeutics is -2.38
What is the reporting currency for Rani Therapeutics?
Rani Therapeutics reports financial results in USD
What is the latest annual profit for Rani Therapeutics?
The latest annual profit of Rani Therapeutics is USD -33.97M
What is the registered address of Rani Therapeutics?
The registered address for Rani Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Rani Therapeutics website address?
The website address for Rani Therapeutics is www.ranitherapeutics.com
Which industry sector does Rani Therapeutics operate in?
Rani Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

RANI Discussion

View Posts
PonkenPlonken PonkenPlonken 5 days ago
neglected
cant get no love. Had hopes once because of the oral administration GLP1 platform
people dont like needles
πŸ‘οΈ0
David bond David bond 2 months ago
There are no short shares available as of 11.45 am....dont sell I believe a shore squeeze will happen today if not then in the morning
πŸ‘οΈ0
1hot toddy 1hot toddy 2 months ago
AVERAGE PRICE OF 5 ANALYSIS IS $12 $$$$$$$$$$$$
πŸ‘οΈ0
1hot toddy 1hot toddy 2 months ago
16000 SHARES ON THE BID $$$$$$$$$$ BACK OVER $3 $$$$$$$$$$$$$$$
πŸ‘οΈ0
David bond David bond 2 months ago
Don't listen to woodpecker he is obvious short selling and likes to make up stories
πŸ‘οΈ0
David bond David bond 2 months ago
Don't listen to woodpecker he is obvious short selling and likes to make up stories
πŸ‘οΈ0
Woodpecker3 Woodpecker3 2 months ago
In the course of your due diligence did you read that the company is at risk of not being able to continue as an on-going concern? This was in the 10Q from June 2024. I would also take a look at the balance sheet and income statement. There you will realize $RANI is teetering on the brink of bankruptcy. It has no product, has multi million dollar losses for the last several years the most recent one 67 million $. It is burning through its cash. Caveat Emptor...Buyer beware
πŸ‘οΈ0
1hot toddy 1hot toddy 2 months ago
investor bought the 3 mil shares at $3. its now 2.40 so we get to buy lower. great news for co as they get $10 mil. its takes money to make money. co at money making phase and employees bought big time. this is guaranteed to go up rest of week. i got my money on it and average price of 5 analysis is $12 $$$$$$$$$
πŸ‘οΈ0
Woodpecker3 Woodpecker3 2 months ago
So the plot thickens.. RANI was prepping itself for the share and warrant offered today to Maxim Group. RANI is running out of cash. Without revenues and no guarantee of ever having a product to sell, RANI is scrambling for the pending reality that it will be unable to run as an ongoing concern. This was noted in its 10Q to the SEC in June.
πŸ‘οΈ0
Woodpecker3 Woodpecker3 2 months ago
RANI Therapeutics 10Q to Securities and Exchange Commission stated that due to liquidity issues there is substantial doubt regarding the company's ability to continue as a going concern. (See link below to SEC 10Q and read page 10)

https://www.marketwatch.com/investing/stock/rani/financials/secfilings?docid=17734871
πŸ‘οΈ0
Woodpecker3 Woodpecker3 2 months ago
There is substantial doubt regarding the Company’s ability to continue as a going concern

The Company has incurred recurring losses since its inception, including net losses of $28.1 million for the six months ended June 30, 2024. As of June 30, 2024, the Company had an accumulated deficit of $87.2 million and for the six months ended June 30, 2024, had negative cash flows from operations of $18.4 million. As of June 30, 2024, cash, cash equivalents and marketable securities totaled $30.9 million. Based on its available cash resources and current operating plan, there is substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year after the date that its financial statements for the six months ended June 30, 2024 are issued.
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 2 months ago
Im baffled. See the post I am replying too-- was in broad daylight. And only now discovered via this stoopid Oppenheimer note LOL
I love fundamental analysis!!!! So rewarding!
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 2 months ago
oral GLP1...... boom
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 months ago
RANI: If Oppenheimer says so, right?????
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RANI under $4
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 7 months ago
MGRX did 330% today on news of planning to distribute an oral version of GLP1 sometime in the future.
This company has the platform to produce a promising oral GLP1 option right now.

You also get some free shots at the goal in 4 other indications.
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
RANI under $10
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 8 months ago
wants sooo much more
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 8 months ago
shake shake the tree
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...HERE COMES 9.00...LOL
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...8 DOLLA FLOOR BEING BUILT
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI 8 DOLLA...FORTUNE COOKIE WAS RIGHT....LMAO
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...LETS SEE 8 BUCKS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
SOMEONE WITH BRAINS AROUND HERE
👍️ 1
TrendTrade2016 TrendTrade2016 8 months ago
RANI...GAPPING TO 7.50...LMAO...WHAT A CALL FROM THE HOUSE OF TREND
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 8 months ago
$RANI can clear worries about GLP adm.
No sellers in consecutive sessions.
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
ITS RAINING AGAIN WITH RANI...IS TIM ON THIS ONE?!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...LET THEM CHASE THE ALGO FABRICATIONS WHILE WE WATCH RANI TREND TO 7.00
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...HERE COMES 7.00
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...BREAKING NEW HIGH
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...BREAKING 6.00...BIO BEAST!!!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...ITS RAINING AGAIN
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...HERE WE GO
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI....BIO MONSTER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...THIN AS THIN...ARCA BID
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 8 months ago
RANI...NEXT BIO BEAST READY TO BEAST
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock